Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response

Pengfei Diao; Yue Jiang; Yuanyuan Li; Xiang Wu; Jin Li; Chen Zhou; Lei Jiang; Wei Zhang; Enshi Yan; Ping Zhang; Xu Ding; Heming Wu; Hua Yuan; Jinhai Ye; Xiaomeng Song; Linzhong Wan; Yunong Wu; Hongbing Jiang; Yanling Wang; Jie Cheng

doi:10.1136/jitc-2021-002434

Article info

PDF

PDF +
Supplementary
Material

XML

Immunotherapy biomarkers

Original research

Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response

Authors

Pengfei Diao Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Yue Jiang Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Yuanyuan Li Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Xiang Wu Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Jin Li Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Chen Zhou Department of Oral and Maxillofacial Surgery, Jiangnan University, Wuxi, Jiangsu, China PubMed articles Google scholar articles
Lei Jiang Department of Oral and Maxillofacial Surgery, Lianyungang No 1 People's Hospital, Lianyungang, Jiangsu, China PubMed articles Google scholar articles
Wei Zhang Department of Oral Pathology, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Enshi Yan Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Ping Zhang Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Xu Ding Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Heming Wu Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Hua Yuan Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Jinhai Ye Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Xiaomeng Song Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Linzhong Wan Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Yunong Wu Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Hongbing Jiang Department of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Yanling Wang Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles
Jie Cheng Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Surgery, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China PubMed articles Google scholar articles

Citation

Diao P, Jiang Y, Li Y, et al

Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response

Journal for ImmunoTherapy of Cancer 2021;9:e002434. doi: 10.1136/jitc-2021-002434

Online issue publication

February 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password